久久日本理伦片aaaaaaa_精品一区二区视频在线_国产麻豆精品久久一二三_校草太大了h

Liver disease

We started with liver drug research, and we have a well developed pipeline for liver diseases. At present, we have introduced hepatitis B (HBV), hepatitis C (HCV), non-alcoholic fatty liver disease (NASH), liver cancer (HCC) and other related drugs for liver disease. Such as Tenofovir alafenmide, Obeticholic acid,Velpatasvir, Asunaprevir, Grazoprevir, Ledipasvir, Daclatasvir,Sofosbuvir,Lenvatinib etc.

Oncology

Paying attention to public health and solving the most difficult problems are the best embodiment of our customer supreme aim. Our team have break through the problem of drug research and development, enjoy solving problems for customers, and bring health benefits to patients. We focus on the following drugs.Such as Osimertinib, Elagolix, Anamorelin, Ribociclib,Ruxolitinib,etc.

Interest hotspots

In addition to liver disease and cancer, we are also interested in heavy, scarce, and difficult drugs. At present, we have developed the following projects. Drugs such as eczema(Crisaborole), onychomycosis (Amorolfine), hypertension (Nebivolol), chronic heart failure (Sacubitril/Valsatran, LCZ-696)etc.

> Recent News

Welcome to our booth

CPhI Shanghai

2019.6.18-20

Booth No.:W4G30

CPhI Worldwide Europe

2019.10.xx-xx

Booth No.:xxxx

CPhI India

2019.11.xx-xx

Booth No.: XXXX

Contact us for more details

sales@halosyntech.com
?

Book Now

閩公網(wǎng)安備 35020502000247號